Article highlights results from successful Phase 2a clinical trial for lead candidate, LP-10
Lipella expects to initiate Phase 2b clinical trial in LP-10 in early 2024
PITTSBURGH, Pa., Sept. 21,.
/PRNewswire/ Lipella Pharmaceuticals Inc. (Nasdaq: "LIPO") ("Lipella," "our, "us" or the "Company"), a clinical-stage biotechnology company addressing.
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.